SEC CIK 1181000
SUSSMAN ELLIOT J MD MBA
Reported ownership across 2 companies, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| UHTview stock → | 7,525 | 2017-06-07 |
| UHSview stock → | 7,330 | 2026-05-20 |
Position History — UHS
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — UHS
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2026-05-20 | Grant / award | 1,217 | $0.00 | 7,330 |
| 2026-03-13 | Option exercise (derivative) | 1,250 | $0.00 | 0 |
| 2026-03-13 | Open-market sale | 356 | $193.37 | 6,113 |
| 2026-03-13 | Tax withholding | 894 | $194.27 | 6,469 |
| 2026-03-13 | Option exercise | 1,250 | $138.80 | 7,363 |
| 2026-03-11 | Option exercise (derivative) | 1,250 | $0.00 | 1,250 |
| 2026-03-11 | Open-market sale | 318 | $186.35 | 6,113 |
| 2026-03-11 | Tax withholding | 932 | $186.28 | 6,431 |
| 2026-03-11 | Option exercise | 1,250 | $138.80 | 7,363 |
| 2025-10-29 | Option exercise (derivative) | 2,500 | $0.00 | 2,500 |
| 2025-10-29 | Open-market sale | 965 | $225.70 | 6,113 |
| 2025-10-29 | Tax withholding | 1,535 | $226.15 | 7,078 |
| 2025-10-29 | Option exercise | 2,500 | $138.80 | 8,613 |
| 2025-05-14 | Grant / award | 1,065 | $0.00 | 6,113 |
| 2024-08-13 | Option exercise (derivative) | 2,500 | $0.00 | 0 |
| 2024-08-13 | Open-market sale | 1,722 | $218.08 | 5,048 |
| 2024-08-13 | Option exercise | 2,500 | $67.69 | 7,548 |
| 2024-08-13 | Tax withholding | 778 | $217.74 | 6,770 |
| 2024-07-26 | Option exercise (derivative) | 2,500 | $0.00 | 5,000 |
| 2024-07-26 | Option exercise (derivative) | 2,500 | $0.00 | 2,500 |
| 2024-07-26 | Tax withholding | 2,459 | $210.00 | 7,589 |
| 2024-07-26 | Open-market sale | 2,541 | $210.00 | 5,048 |
| 2024-07-26 | Option exercise | 2,500 | $67.69 | 7,548 |
| 2024-07-26 | Option exercise | 2,500 | $138.80 | 10,048 |
| 2024-05-15 | Grant / award | 1,097 | $0.00 | 5,048 |
| 2024-03-01 | Option exercise (derivative) | 5,000 | $0.00 | 5,000 |
| 2024-03-01 | Option exercise (derivative) | 2,500 | $0.00 | 7,500 |
| 2024-03-01 | Open-market sale | 3,492 | $170.99 | 3,951 |
| 2024-03-01 | Option exercise | 5,000 | $67.69 | 8,951 |
| 2024-03-01 | Option exercise | 2,500 | $138.80 | 11,451 |
| 2024-03-01 | Tax withholding | 4,008 | $171.10 | 7,443 |
| 2023-12-13 | Option exercise (derivative) | 5,000 | $0.00 | 0 |
| 2023-12-13 | Tax withholding | 4,486 | $149.40 | 3,951 |
| 2023-12-13 | Option exercise | 5,000 | $134.02 | 8,437 |
| 2023-05-17 | Grant / award | 1,488 | $0.00 | 3,437 |
| 2023-04-12 | Option exercise (derivative) | 2,500 | $0.00 | 0 |
| 2023-04-12 | Tax withholding | 2,231 | $134.08 | 1,949 |
| 2023-04-12 | Option exercise | 2,500 | $134.08 | 4,180 |
| 2022-05-18 | Grant / award | 1,680 | $0.00 | 1,680 |
| 2021-05-10 | Option exercise (derivative) | 5,000 | $0.00 | 5,000 |
| 2021-05-10 | Option exercise (derivative) | 7,500 | $0.00 | 2,500 |
| 2021-05-10 | Option exercise | 7,500 | $157.59 | 7,500 |
| 2021-05-10 | Option exercise | 5,000 | $157.59 | 12,500 |
| 2021-05-10 | Open-market sale | 2,553 | $157.88 | 0 |
| 2021-05-10 | Tax withholding | 9,947 | $157.59 | 2,553 |
| 2021-03-17 | Grant / award (derivative) | 10,000 | $138.80 | 10,000 |
| 2020-03-18 | Grant / award (derivative) | 10,000 | $67.69 | 10,000 |
| 2019-03-20 | Grant / award (derivative) | 10,000 | $134.02 | 10,000 |
| 2018-04-13 | Grant / award (derivative) | 10,000 | $119.64 | 10,000 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.